Crescent Biopharma (CBIO) Current Assets (2013 - 2026)
Crescent Biopharma (CBIO) reported Current Assets of $195.6 million for Q1 2026, up 3163.64% year-over-year from $6.0 million in Q1 2025, and down 17.36% on a QoQ basis from $236.7 million in Q4 2025.
Crescent Biopharma (CBIO) has 14 years of Current Assets data on file, last reported at $195.6 million in Q1 2026.
- Quarterly Current Assets rose 3163.64% year-over-year to $195.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $195.6 million (up 3163.64% YoY) and the FY2025 annual result came in at $236.7 million, up 579.96% from the prior year.
- Current Assets retreated to $195.6 million in Q1 2026 per CBIO's latest filing, from $236.7 million in the prior quarter.
- Across five years, Current Assets topped out at $236.7 million in Q4 2025 and bottomed at $6.0 million in Q1 2025.
- The 5-year median for Current Assets is $53.8 million (2022), against an average of $76.6 million.
- The widest annual swing landed in 2025, when Current Assets slumped 81.99%; it then soared 3163.64% in 2026.
- Tracing CBIO's Current Assets over 5 years: stood at $50.7 million in 2022, then fell by 13.65% to $43.8 million in 2023, then slipped by 20.52% to $34.8 million in 2024, then jumped by 579.96% to $236.7 million in 2025, then retreated by 17.36% to $195.6 million in 2026.
- Per Business Quant, the three latest CBIO Current Assets figures stand at $195.6 million (Q1 2026), $236.7 million (Q4 2025), and $134.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 10.37 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 37.31 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 1.25 Bn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 73.04 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 3.59 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 11.73 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 18.21 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 4.22 Bn |
| 10 | Crescent Biopharma | 569.36 Mn | 380.20 Mn | - | 195.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 195.56 Mn |
| Dec 31, 2025 | 236.66 Mn |
| Sep 30, 2025 | 134.56 Mn |
| Jun 30, 2025 | 154.23 Mn |
| Mar 31, 2025 | 5.99 Mn |
| Dec 31, 2024 | 34.80 Mn |
| Sep 30, 2024 | 15.65 Mn |
| Jun 30, 2024 | 23.86 Mn |
| Mar 31, 2024 | 33.27 Mn |
| Dec 31, 2023 | 43.79 Mn |
| Sep 30, 2023 | 52.01 Mn |
| Jun 30, 2023 | 60.37 Mn |
| Mar 31, 2023 | 68.09 Mn |
| Dec 31, 2022 | 50.71 Mn |
| Sep 30, 2022 | 53.85 Mn |
| Jun 30, 2022 | 61.26 Mn |
| Mar 31, 2022 | 77.46 Mn |
| Dec 31, 2021 | 90.79 Mn |
| Sep 30, 2021 | 104.13 Mn |
| Jun 30, 2021 | 120.31 Mn |
| Mar 31, 2021 | 133.71 Mn |
| Dec 31, 2020 | 138.27 Mn |
| Sep 30, 2020 | 145.64 Mn |
| Jun 30, 2020 | 153.36 Mn |
| Mar 31, 2020 | 156.88 Mn |
| Dec 31, 2019 | 162.53 Mn |
| Sep 30, 2019 | 174.80 Mn |
| Jun 30, 2019 | 186.47 Mn |
| Mar 31, 2019 | 198.39 Mn |
| Dec 31, 2018 | 212.27 Mn |
| Sep 30, 2018 | 222.43 Mn |
| Jun 30, 2018 | 232.92 Mn |
| Mar 31, 2018 | 246.11 Mn |
| Dec 31, 2017 | 127.22 Mn |
| Sep 30, 2017 | 113.89 Mn |
| Jun 30, 2017 | 119.65 Mn |
| Mar 31, 2017 | 35.29 Mn |
| Dec 31, 2016 | 40.52 Mn |
| Sep 30, 2016 | 46.52 Mn |
| Jun 30, 2016 | 54.53 Mn |
| Mar 31, 2016 | 39.51 Mn |
| Dec 31, 2015 | 47.24 Mn |
| Sep 30, 2015 | 54.48 Mn |
| Jun 30, 2015 | 60.77 Mn |
| Mar 31, 2015 | 47.34 Mn |
| Dec 31, 2014 | 56.12 Mn |
| Sep 30, 2014 | 61.95 Mn |
| Jun 30, 2014 | 67.10 Mn |
| Mar 31, 2014 | 57.69 Mn |
| Dec 31, 2013 | 4.88 Mn |